Welcome to our dedicated page for MOXC news (Ticker: MOXC), a resource for investors and traders seeking the latest updates and insights on MOXC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MOXC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MOXC's position in the market.
Moxian, Inc. (NASDAQ: MOXC) announced the completion of its reorganization into Moxian (BVI) Inc. on August 16, 2021. As part of this transition, each share of Moxian’s common stock was converted into an ordinary share of Moxian BVI. Shareholders will retain the same number of shares as before the merger. Trading of Moxian BVI's ordinary shares commenced on the NASDAQ Capital Market on August 17, 2021, under the symbol 'MOXC,' identical to the previous stock symbol.
Founded in 2013, Moxian provides Internet media marketing services and operates in Hong Kong, Shenzhen, Beijing, and Malaysia.
Moxian, Inc. (MOXC) announced the termination of its proposed merger with Btab Group Inc. by mutual consent, as per their Share Exchange Agreement from August 27, 2020. The merger's cancellation raises questions about future strategic directions. Additionally, the company disclosed the resignations of board members, James Tan Meng Dong and Dr. David Cheang Sien Chan, effective February 28, 2021. The board now includes Hao Qinghu as the CEO and three independent directors, who have served since 2019.
Moxian, Inc. (MOXC) has announced it has regained compliance with Nasdaq listing rules regarding market value. After being notified of a non-compliance situation due to a market value below $35 million, the company successfully raised its market value to over $35 million for the required period. This compliance matter is now closed as of September 16, 2020. Moxian is also progressing towards a merger with Btab Group, an e-commerce firm based in Australia, which is anticipated to finalize by December 31, 2020, pending shareholder and regulatory approvals.
Moxian, Inc. (MOXC) announced a partnership with Btab Group for a merger, offering 10,000 online storefronts to small businesses at no setup cost. This initiative aims to assist struggling entrepreneurs by providing direct access to manufacturers and competitive pricing on products. Btab's extensive product line and fulfillment services will enhance small businesses' competitiveness against larger companies. The program underscores Btab's commitment to supporting small enterprises during challenging economic conditions.
Moxian, Inc. (MOXC) announced plans to acquire Btab Group Inc. following a Share Exchange Agreement on August 27, 2020. Btab is negotiating to acquire a food processing company in India, projected to generate approximately USD 15 million in annual revenue. This strategic move aims to enhance Btab's global supply chain and provide added value to its merger with Moxian. Chairman William Yap expressed satisfaction with Btab's growth trajectory and its focus on value creation.
Moxian, Inc. (MOXC) has signed a definitive Share Exchange Agreement with Btab Group Inc., following a Letter of Intent from August 8. Moxian will issue about 59 million common shares and 50 million Class A preferred shares in exchange for Btab's equity, creating a merged entity valued over $400 million, with projected annual revenues of at least $40 million. The agreement is contingent on due diligence, shareholder approval, and a financing commitment of up to $50 million from Btab, which will also nominate three directors post-merger.